5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists

Compounds of the formula I in which B, D, E, R, W, Y, Z, b, c, d, e, f, g and h have the meanings indicated in the claims, are inhibitors of the adhesion and migration of leucocytes and/or antagonists of the adhesion receptor VLA-4 which belongs to the group of integrins. The invention relates to th...

Full description

Saved in:
Bibliographic Details
Main Authors STILZ, HANS ULRICH DR, BARTNIK, ECKART DR, WEHNER, VOLKMAR DR, HULS, CHRISTOPH DR, KNOLLE, JOCHEN DR
Format Patent
LanguageEnglish
Published 01.08.2002
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds of the formula I in which B, D, E, R, W, Y, Z, b, c, d, e, f, g and h have the meanings indicated in the claims, are inhibitors of the adhesion and migration of leucocytes and/or antagonists of the adhesion receptor VLA-4 which belongs to the group of integrins. The invention relates to the use of compounds of the formula I and of pharmaceutical preparations which contain such compounds for the treatment and prophylaxis of diseases which are caused by an undesired extent of leucocyte adhesion and/or leucocyte migration or which are associated therewith or in which cell-cell or cell- matrix interactions which are based on interactions of VLA-4 receptors with their ligands play a part, for example of inflammatory processes, of rheumatoid arthritis or of allergic disorders, and it also relates to the use of compounds of the formula I for the production of pharmaceuticals for use in such diseases. It further relates to novel compounds of the formula I.
Bibliography:Application Number: TW199786116879